PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

LA BioMed research finds hallucinogen can safely ease anxiety in advanced-stage cancer patients

First published study of its kind in 37 years finds improved mood in volunteers receiving psilocybin

LA BioMed research finds hallucinogen can safely ease   anxiety in advanced-stage cancer patients
2010-09-07
(Press-News.org) LOS ANGELES (Sept. 6, 2010) – In the first human study of its kind to be published in more than 35 years, researchers found psilocybin, an hallucinogen which occurs naturally in "magic mushrooms," can safely improve the moods of patients with advanced-stage cancer and anxiety, according to an article published online today in the Archives of General Psychiatry.

Patients enrolled in the study at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) demonstrated improvement of mood and reduction of anxiety up to six months after undergoing treatment, with significance reached at the six-month point on the "Beck Depression Inventory" and at one and three months on the "State-Trait Anxiety Inventory." A third screening tool, the "Profile of Mood States," identified mood improvement after treatment that approached but did not reach significance.

"We are working with a patient population that often does not respond well to conventional treatments," said Charles S. Grob, MD, an LA BioMed principal investigator who led the research team. "Following their treatments with psilocybin, the patients and their families reported benefit from the use of this hallucinogen in reducing their anxiety. This study shows psilocybin can be administered safely, and that further investigation of hallucinogens should be pursued to determine their potential benefits."

Researchers conducted extensive investigations of psychedelic drugs in the 1950s and 1960s and found promising improvements in mood and anxiety, as well as a diminished need for narcotic pain medication among advanced-stage cancer patients. The research was abandoned in the early 1970s in the wake of widespread recreational usage that led to stiff federal laws regulating hallucinogens.

"Political and cultural pressures forced an end to these studies in the 1970s," said Dr. Grob. "We were able to revive this research under strict federal supervision and demonstrate that this is a field of study with great promise for alleviating anxiety and other psychiatric symptoms."

The LA BioMed study is the first research publication in several decades to examine the hallucinogen treatment model with advanced-cancer anxiety. Twelve volunteers, ages 36 to 58, with advanced-stage cancer and anxiety were given a moderate dose of 0.2 mg/kg of psilocybin and, on a separate occasion, a placebo. Neither the volunteers nor the researchers monitoring them knew whether they'd been given a placebo or psilocybin.

The two experimental sessions took place several weeks apart in a hospital clinical research unit at Harbor-UCLA Medical Center, where Dr. Grob is a professor of psychiatry. The research volunteers were monitored for the six hours following their dose. The volunteers were encouraged to lie in bed, wear eye shades and listen to music during the first few hours after ingesting the medication or the placebo. They were interviewed after the six-hour session and over the next six months to assess the outcome of the treatment.



INFORMATION:



To see interviews with two of the research volunteers, please visit:

http://www.doc-jukebox.com/film/medical-research-psychedelics/annies-psilocybin-therapy
http://blip.tv/file/510857

This study was funded by the Heffter Research Institute, the Betsy Gordon Foundation and the Nathan Cummings Foundation (with the support and encouragement of James R. Cummings). Infrastructural support for this study was provided via grant M01-RR00425 from the National Institutes of Health for the General Clinical Research Unit at LA BioMed.

About LA BioMed

Founded in 1952, LA BioMed is one of the country's leading nonprofit independent biomedical research institutes. It has more than 150 fulltime and part-time researchers conducting studies into improved treatments and cures for cancer, inherited diseases, infectious diseases, illnesses caused by environmental factors and more. It also educates young scientists and provides community services, including immunization and childhood nutrition programs. LA BioMed is academically affiliated with the David Geffen School of Medicine at UCLA and located on the campus of Harbor-UCLA Medical Center. For more information, please visit www.LABioMed.org


[Attachments] See images for this press release:
LA BioMed research finds hallucinogen can safely ease   anxiety in advanced-stage cancer patients

ELSE PRESS RELEASES FROM THIS DATE:

Are white homosexual men still taking too many HIV risks?

2010-09-07
Risky sexual behavior among members of a subset of the gay community is still adding to the spread of HIV. Research published in the open access journal BMC Infectious Diseases has found that young white homosexual men have an important contribution in the local spread of HIV. Despite increased education and awareness of HIV in the Western world, the number of new infections continues to rise each year. To try and understand this phenomenon, researchers from Ghent University in Belgium compared the genetic information of viruses isolated from more than 500 patients – ...

Some children with autism show a preference for geometric patterns at an early age

2010-09-07
A fixation on geometric patterns may be associated with autism in children as young as 14 months, according to a report published online today that will appear in the January 2011 print issue of Archives of General Psychiatry, one of the JAMA/Archives journals. "It is undeniable that early treatment can have a significant positive impact on the long-term outcome for children with an autism spectrum disorder," the authors write as background information in the article. "Early treatment, however, generally relies on the age at which a diagnosis can be made, thus pushing ...

Hallucinogen appears safe, may improve mood among patients with advanced-stage cancer and anxiety

2010-09-07
A pilot study suggests the hallucinogen psilocybin may be feasible and safe to administer to patients with advanced-stage cancer and anxiety, with promising effects on mood, according to a report published online today that will appear in the January 2011 print issue of Archives of General Psychiatry, one of the JAMA/Archives journals. "In recent years, there has been a growing awareness that the psychological, spiritual and existential crises often encountered by patients with cancer and their families need to be addressed more vigorously," the authors write as background ...

Study examines association between urban living and psychotic disorders

2010-09-07
The association between psychotic disorders and living in urban areas appears to be a reflection of increased social fragmentation present within cities, according to a report in the September issue of Archives of General Psychiatry, one of the JAMA/Archives journals. "There is a substantial worldwide variation in incidence rates of schizophrenia," the authors write as background in the article. "The clearest geographic pattern within this distribution of rates is that urban areas have a higher incidence of schizophrenia than rural areas." Characteristics of neighborhoods ...

Combining medication and psychosocial treatments may benefit patients with early-stage schizophrenia

2010-09-07
Patients with early-stage schizophrenia who receive a combination of medication and a psychosocial intervention appear less likely to discontinue treatment or relapse—and may have improved insight, quality of life and social functioning—than those taking medication alone, according to a report in the September issue of Archives of General Psychiatry, one of the JAMA/Archives journals. Antipsychotic drugs are the mainstay of therapy for patients with schizophrenia, but long-term therapy is associated with adverse effects and poor adherence, according to background information ...

Compounds in non-stick cookware may be associated with elevated cholesterol in children and teens

2010-09-07
Children and teens with higher blood levels of chemicals used in the production of non-stick cookware and waterproof fabrics appear more likely to have elevated total and LDL cholesterol levels, according to a report in the September issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals. Humans are exposed to the man-made compounds known as perfluoroalkyl acids—including perfluorooctanoic acid (PFOA) and perfluorooctanesulfonate (PFOS)—through drinking water, dust, food packaging, breast milk, cord blood, microwave popcorn, air and occupational ...

Short nighttime sleep duration among infants, young children associated with obesity in later life

2010-09-07
Insufficient amounts of nighttime sleep among infants and preschool-aged children may be a significant risk factor for developing childhood obesity, according to a report in the September issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals. Additionally, napping does not appear to be an adequate substitute for nighttime sleep in terms of preventing obesity. "Obesity – defined as having age- and sex-specific body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) at or above the 95th percentile ...

Parents at highest risk for depression in the first year after child's birth

2010-09-07
More than one-third of mothers and about one-fifth of fathers in the United Kingdom appear to experience an episode of depression between their child's birth and 12th year of age, with the highest rates in the first year after birth, according to a report posted online today that will appear in the November print issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals. "Depression in parents is associated with adverse behavioral, developmental and cognitive outcomes in their children," the authors write as background information in the ...

The brain speaks

The brain speaks
2010-09-07
SALT LAKE CITY, Sept. 7, 2010 – In an early step toward letting severely paralyzed people speak with their thoughts, University of Utah researchers translated brain signals into words using two grids of 16 microelectrodes implanted beneath the skull but atop the brain. "We have been able to decode spoken words using only signals from the brain with a device that has promise for long-term use in paralyzed patients who cannot now speak," says Bradley Greger, an assistant professor of bioengineering. Because the method needs ...

Radiologists identify and treat teenage self-injury

2010-09-07
OAK BROOK, Ill. – Using ultrasound and a minimally-invasive procedure, radiologists can identify and treat patients who engage in a disturbing self-injury behavior known as self-embedding, according to a new study published in the online edition and October print issue of the journal Radiology. "This is a new way for radiologists to impact public and mental health," said the study's senior author, William E. Shiels II, D.O., chairman of the Department of Radiology at Nationwide Children's Hospital in Columbus, Ohio, and president of The Children's Radiological Institute. ...

LAST 30 PRESS RELEASES:

Community partners key to success of vaccine clinic focused on neurodevelopmental conditions

Low-carbon collaborative dual-layer optimization for energy station considering joint electricity and heat demand response

McMaster University researchers uncover potential treatment for rare genetic disorders

The return of protectionism: The impact of the Sino-US trade war

UTokyo and NARO develop new vertical seed distribution trait for soybean breeding

Research into UK’s use of plastic packaging finds households ‘wishcycle’ rather than recycle – risking vast contamination

Vaccine shows promise against aggressive breast cancer

Adverse events affect over 1 in 3 surgery patients, US study finds

Outsourcing adult social care has contributed to England’s care crisis, argue experts

The Lancet: Over 800 million adults living with diabetes, more than half not receiving treatment, global study suggests

New therapeutic approach for severe COVID-19: faster recovery and reduction in mortality

Plugged wells and reduced injection lower induced earthquake rates in Oklahoma

Yin selected as a 2024 American Society of Agronomy Fellow

Long Covid could cost the economy billions every year

Bluetooth technology unlocks urban animal secrets

This nifty AI tool helps neurosurgeons find sneaky cancer cells

Treatment advances, predictive biomarkers stand to improve bladder cancer care

NYC's ride-hailing fee failed to ease Manhattan traffic, new NYU Tandon study reveals

Meteorite contains evidence of liquid water on Mars 742 million years ago

Self-reported screening helped reduce distressing symptoms for pediatric patients with cancer

Which risk factors are linked to having a severe stroke?

Opening borders for workers: Abe’s profound influence on Japan’s immigration regime

How skills from hospitality and tourism can propel careers beyond the industry

Research shows managers of firms handling recalls should review media scrutiny before deciding whether to lobby

New model system for the development of potential active substances used in condensate modifying drugs

How to reduce social media stress by leaning in instead of logging off

Pioneering research shows sea life will struggle to survive future global warming

In 10 seconds, an AI model detects cancerous brain tumor often missed during surgery 

Burden of RSV–associated hospitalizations in US adults, October 2016 to September 2023

Repurposing semaglutide and liraglutide for alcohol use disorder

[Press-News.org] LA BioMed research finds hallucinogen can safely ease anxiety in advanced-stage cancer patients
First published study of its kind in 37 years finds improved mood in volunteers receiving psilocybin